
ASSOCIATION OF NFKB1, NKX2-5, GATA4 AND RANKL
GENE POLYMORPHISMS WITH SPORADIC CONGENITAL
HEART DISEASE IN GREEK PATIENTS Aidinidou L1, Chatzikyriakidou A1, Giannopoulos A2, Karpa V1, Tzimou I2, Aidinidou E3, Fidani L1,* *Corresponding Author: Professor Liana Fidani, Department of General Biology, Medical School,
Aristotle University of Thessaloniki, University Campus, GR-54124, Thessaloniki, Greece. Tel.: +30-
231-099-9165. Fax: +30-231-099-9019. E-mail: sfidani@auth.gr page: 15
|
RESULTS
The association of rs28362491, rs2277923, rs4531631
and rs11785481 polymorphisms are shown in Table 2.
The genotype frequencies of the above variants in CHD
patients and controls were in HWE. The polymorphism
rs28362491 was associated with decreased risk of CHD
with the additive [risk per allele RR genotype (homozygosity
for the wild-type allele); RV genotype (heterozygosity
for the wild-type and non wild-type alleles); VV
genotype (homozygosity for non wild-type allele): p =
0.003], homozygous (VV vs. RR: p = 0.001), heterozygous
(RV vs. RR: p = 0.040), dominant (RV+VV vs. RR:
p = 0.009), recessive (VV vs. RV+RR: p = 0.019) and
allelic model (V vs. R: p = 0.006). Also, decreased risk
was found with the additive (risk per allele RR, RV, VV: p
= 0.004), homozygous (VV vs. RR: p = 0.015), recessive
(VV vs. RV+RR: p = 0.004) and allelic model (V vs. R:
p = 0.004) for polymorphism rs2277923. Additionally,
when the FDR was applied, the association that remained
significant concerned both of rs28362491 and rs2277923
variants, according to allelic model (p = 0.012 and p =
0.008, respectively). There was no statistical difference
of rs4531631 and rs11785481 polymorphism distribution
between the two groups (p >0.05).
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|